Blog

Unsure how to proceed amid tariff uncertainty? Here are no-regrets actions you can take now.

Financial sustainability
Pharmacy
Supply chain
February 28, 2025
Bonnie Lai
Bonnie Lai,
senior vice president and general manager, clinical and physician preference, Vizient
Dana Garcher
Scott Eber,
senior vice president, consulting, Kaufman Hall, a Vizient company
Updated April 3, 2025

Ship with cargo containers

Economic uncertainty is no stranger to healthcare. Since 2020, the healthcare supply chain has faced a global pandemic, natural disasters, port strikes and other unexpected events.

As healthcare looks to another period of uncertainty — namely the impact of tariffs — it’s important to remain vigilant, keep informed and be purposeful about next steps.

Where we are right now, what we know — and what we don’t

Through a series of executive actions, President Donald Trump announced a range of tariffs and trade-related measures April 2, including reciprocal tariffs, that impact multiple countries and industries and offer limited exemptions. The president cites reasons including trade imbalances, national security concerns and unfair trade practices.

The pace, volume and unpredictability of these policy changes creates uncertainty for healthcare providers already operating on tight margins and could impact access to critical supplies, increase procurement costs and introduce new risk to operational stability.

The future may be unclear, but the past has provided lessons that can offer some clarity and guidance.

No-regrets actions to take now

No-regrets moves that healthcare leaders can make now to remain informed and prepared in the months ahead include:

  • Review hospital budget assumptions to support proactive planning. Consider scenario modeling to gain insight into how current and potential tariffs may impact supply expenses and financials. Outline available strategies that could be deployed to mitigate those impacts should they materialize.
  • Create leadership alignment. Establish top-down messaging and decision-making structures that allow for transparent communication and guidance for expense management and engagement of physician and clinical stakeholders. For health systems or hospitals that plan to make decisions based on trade policy, consider how to accurately track these developments and communicate changes or status updates through an established communication plan. Any time there is a supply chain disruption — whether due to a natural disaster or otherwise — hospitals must have the flexibility to make real-time, informed decisions. Having an established structure to do so saves time, reduces confusion and allows for faster implementation of updates or changes to existing processes.
  • Ensure resiliency measures are in place. Establish a list of critical supplies, gain clarity on your inventory, ensure you understand current utilization and ensure cross-references for those supplies are identified. These resiliency best practices will help hospitals implement measures or shift to lower-cost options in scenarios where tariffs could cause disruption to supply.
  • Audit existing local agreements for contract risk. Review contracts for language that may allow suppliers to raise prices due to tariffs or circumstances that might include tariffs. Often, national Group Purchasing Organization (GPO) contracts have additional provisions included within their language that local contracts may not. It may be worthwhile to consider where these national agreements could add protection.
  • Identify savings initiatives that could offset price increases. Proactively identify ways to manage expenses. Determine where to standardize to more cost-effective products or reduce waste through physician and clinician engagement. For example, would it make sense to continue to use a premium product for all patients or reserve it for those who would have incremental clinical benefit? Some hospitals also are considering pausing the adoption of new technology to avoid additional costs. Additionally, double-check charge capture and revenue cycle adjustments and ensure there is accurate coding and billing for high-cost items.

Actions that may make sense down the road

It’s simply too early to tell if the following strategies make sense to implement now given how little we know about the evolving landscape. It’s prudent to consider how these strategies could reshape a health system or supply chain budget if implemented without thoughtful deliberation.

  • Bulk buys and/or future buys. Protective purchasing often leads to supply shortages, even when a shortage may not have occurred otherwise, and over-purchasing of the wrong supplies may lead to excess inventory and risk of expiration. Avoid putting the cart before the horse and wait for more clarity on which tariffs will proceed before panic-buying products that may never be impacted.
  • Multi-source strategies. Healthcare leaders learned during the pandemic that diversifying their supplier base was an unexpected necessity. Understanding where suppliers are located and where their products are sourced helps hospitals anticipate risks. However, given that price increases are discretionary, healthcare organizations in existing committed programs with suppliers are less likely to experience price increases than those who aren’t committed, as it would require renegotiating mutually beneficial long-term contracts. In a scenario where alternative suppliers are needed, Vizient contracts could be an additional resource for managing spend beyond committed agreements.
  • Prioritizing domestic manufacturers. A common risk-mitigating tactic to reduce supply chain disruptions is to domestically source products and materials; however, domestic manufacturing isn’t immune to natural disasters, labor strikes or other changes outside of tariffs. Shifting to domestic manufacturers — without fully understanding the scope of the organization’s existing supply chain — could significantly impact budgets in the short-term as domestic manufacturing can sometimes be more expensive than global sourcing due to higher labor costs, regulatory requirements and overhead expenses. Additionally, many raw materials, like steel or aluminum, are sourced globally by domestic manufacturers, which can make it challenging for them to supply products that use these materials.

While there are still so many unknowns, healthcare leaders can be proactive in their approach to managing their supply chain. Understanding where products are sourced and scenario modeling accordingly can help bring clarity and enable leaders to proceed with confidence.

Learn more about Vizient’s supply assurance programs and resources.

Authors
Bonnie Lai

Bonnie Lai is a mission-driven leader who is passionate about making healthcare more affordable and accessible. Lai currently serves as senior vice president and general manager of Vizient's Spend Management solutions for clinician and physician preference items.

Lai received her Ph.D. in biomedical engineering from Duke University, where she was a National Science Foundation fellow. She received her bachelor’s degree from Northwestern University in biomedical engineering and art theory and practice.

Scott Eber

Scott Eber is a Senior Vice President in Kaufman Hall’s Performance Improvement practice with more than 25 years of consulting and industry experience serving the healthcare, manufacturing, and publishing industries through a variety of process optimization, cost reduction, post-merger integration and client executive roles.

He has been responsible for several successful, large scale, complex engagements at some of the most recognized health systems in the country. He specializes in supply chain transformation, clinical supply standardization, physician engagement, strategic sourcing of clinical and non-clinical supplies and services and the streamlining of capital purchase requirements.

Eber was previously a Director within Guidehouse’s Commercial Payer/Provider practice where he led the Supply Chain practice and served as the engagement executive for numerous engagements.

He earned his BBA in Finance from the University of Massachusetts Isenberg School of Management and his MBA in Finance from Fordham University’s Graduate School of Business.